News – Oxular

Keep up with Oxular

Explore our latest news and stories covering technology, retinal health, our people, events, press, and more. You can also follow us on LinkedIn for updates as they happen.

Keep up with Oxular

Explore our latest news and stories covering technology, retinal health, our people, events, press, and more. You can also follow us on LinkedIn for updates as they happen.

Latest News

IND clearance for OXU-001

We are thrilled to announce the IND clearance for suprachoroidal OXU-001, supporting it’s advancement into

Oxular at Dry AMD Conference

Oxular’s CMO, Friedrich Asmus, MD, spoke at the Dry AMD Therapeutic Development conference in Boston, presenting

New Oxular CBO – James Jogerst

OXFORD, UK – November 7, 2022 – Oxular Limited, a clinical-stage retinal therapeutics company developing

Oxular Sponsors ISU 2022

Oxular is thrilled to sponsor ISU 2022 in Utrecht, The Netherlands, and introduce the Oxulumis®

Oxular in Drug Discovery World

An excellent summary about the potential of our lead program, OXU-001, from Drug Discovery World.

2 x Triesence® doses; nearly one year of response

Oxular’s Senior Medical Advisor, Prof. Marc de Smet, presented on “Managing CME via the Suprachoroidal

Drug Delivery OIS presentation

Oxular’s Chief Scientific Officer, Ron Yamamoto, shared an overview of Oxular’s drug delivery formulations at

Oxular presents at Eyecelerator

Our CEO, Tom Cavanagh, presented an overview of Oxular’s retinal therapeutics platform at Eyecelerator, during

Oxular in Retina Today

Oxular was mentioned in this great article by Dr. Sivaprasad in Retina Today, on the

Follow us on

Limited company registered in England and Wales (Registration No. 09331313) VAT No. GB 244 5883 81

Copyright Oxular Limited
Website designed by Emerald Grove Studio

Website built by THRH Consulting